Jyong Biotech Ltd.
MENS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001954488
No open-market purchases or sales by Jyong Biotech Ltd. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $1.01M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Jyong Biotech Ltd. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 2 | 8 | +6 |
| Shares | 93.9K | 105.4K | +11.6K (+12.3%) |
| Value | $781.2K | $4.15M | +$3.37M (+431.5%) |
New holders (6)
Institutions that held Jyong Biotech Ltd. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 53,844 | $2.12M | 0.00% |
| Millennium Management LLC | 13,013 | $512.5K | 0.00% |
| Morgan Stanley | 2,871 | $113.1K | 0.00% |
| BNP Paribas Arbitrage, SA | 1,698 | $66.9K | 0.00% |
| UBS Group AG | 537 | $21.1K | 0.00% |
| Tower Research Capital LLC (TRC) | 26 | $1.02K | 0.00% |
Sold out (0)
Institutions that held Jyong Biotech Ltd. at the end of Q2 2025 and filed for Q3 2025 without it.
None.